Identifying an important drug interaction

Recent research from Chilmark (mHealth in the Enterprise: Trends, Opportunities and Challenges.) is predicting that the mHealth market will see exponential growth over the next several years.  The research is predicting that mobile applications that can connect physicians to other hospital HIS such as CPOE and EMR will be the fastest growing group.  This leads us to consider how this trend will impact patient safety and workflows.  As more mHealth technology is developed, there will be a focus on clinical decision support tools within these applications.  Physicians will be looking for guidance on drug-drug interactions, allergy screening and therapeutic dosing recommendations within these mHealth apps.  Making sure that the information behind these systems is founded on current clinical guidelines and expert dosing recommendations will be the key to realizing an actual improvement in patient care.